Norris Medicines Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 17, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	156	134	168	136	105	350
Market Cap Growth	-9.73%	-20.44%	23.38%	30.14%	-70.10%	437.69%
Enterprise Value	371	348	383	351	319	550
Last Close Price	15.58	13.35	16.78	13.60	10.45	34.95
PS Ratio	2.06	1.64	2.88	2.41	1.25	3.70
PB Ratio	-1.03	-0.88	-1.13	-1.00	-0.84	-3.27
P/FCF Ratio	27.43	23.51	34.17	80.65	8.94	-
P/OCF Ratio	26.98	23.11	32.90	80.11	8.71	-
EV/Sales Ratio	4.90	4.27	6.59	6.23	3.82	5.83
EV/EBITDA Ratio	74.05	48.94	-	-	34.52	-
EV/EBIT Ratio	-	158.42	-	-	108.08	-
EV/FCF Ratio	65.31	61.19	78.09	208.24	27.30	-
Debt / Equity Ratio	-1.42	-1.42	-1.45	-1.58	-1.72	-1.97
Debt / EBITDA Ratio	42.99	30.32	-	-	23.13	-
Debt / FCF Ratio	-	37.91	43.95	127.63	18.30	-
Net Debt / Equity Ratio	-1.42	-1.42	-1.45	-1.58	-1.72	-1.97
Net Debt / EBITDA Ratio	42.95	30.29	-97.40	-120.43	23.11	-334.03
Net Debt / FCF Ratio	-	37.88	43.87	127.41	18.28	-19.78
Asset Turnover	-	0.61	0.42	0.40	0.60	0.56
Inventory Turnover	-	1.06	0.83	0.72	1.25	1.48
Quick Ratio	-	0.13	0.14	0.12	0.14	0.16
Current Ratio	-	0.61	0.63	0.67	0.64	0.63
Return on Assets (ROA)	-	1.03%	-3.38%	-3.36%	1.32%	-2.65%
Return on Capital Employed (ROCE)	-	6.50%	-20.70%	-15.10%	4.90%	-9.70%
Earnings Yield	-2.36%	-2.10%	-7.37%	-8.72%	-16.74%	-9.34%
FCF Yield	3.65%	4.25%	2.93%	1.24%	11.19%	-3.05%
Buyback Yield / Dilution	0.10%	-0.21%	-	-	-	-